Literature DB >> 24002787

Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian experts.

Marco Cicardi1, Paolo Bellis, Giuliano Bertazzoni, Mauro Cancian, Maurizio Chiesa, Paolo Cremonesi, Pietro Marino, Nicola Montano, Claudia Morselli, Francesco Ottaviani, Roberto Perricone, Massimo Triggiani, Andrea Zanichelli.   

Abstract

Angioedema attacks, characterized by the transient swelling of the skin and mucosae, are a frequent cause of visits to the emergency department. Swellings of the oral cavity, tongue, or larynx can result in life-threatening airway obstruction, while abdominal attacks can cause severe pain and often lead to unnecessary surgery. The underlying pathophysiologic process resulting in increased vascular permeability and plasma extravasation is mediated by vasoactive molecules, most commonly histamine and bradykinin. Based on the mediator involved, distinct angioedema forms can be recognized, calling for distinct therapeutic approaches. Prompt recognition is challenging for the emergency physician. The low awareness among physicians of the existence of rare forms of angioedema with different aetiologies and pathogenesis, considerably adds to the problem. Also poorly appreciated by emergency personnel may be the recently introduced bradykinin-targeted treatments. The main objective of this consensus statement is to provide guidance for the management of acute angioedema in the emergency department, from presentation to discharge or hospital admission, with a focus on identifying patients in whom new treatments may prevent invasive intervention.

Entities:  

Mesh:

Year:  2013        PMID: 24002787     DOI: 10.1007/s11739-013-0993-z

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  47 in total

1.  Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant.

Authors:  Peter W Schmidt; Michael M Hirschl; Franz Trautinger
Journal:  J Am Acad Dermatol       Date:  2010-06-15       Impact factor: 11.527

Review 2.  Hereditary angio-oedema.

Authors:  Hilary Longhurst; Marco Cicardi
Journal:  Lancet       Date:  2012-02-04       Impact factor: 79.321

3.  Hereditary angioedema: a survey of UK emergency departments and recommendations for management.

Authors:  Thiagarajan Jaiganesh; Chris Hughan; Anthony Webster; Claire Bethune
Journal:  Eur J Emerg Med       Date:  2012-08       Impact factor: 2.799

4.  The early treatment of bradykinin angioedema, a challenge for emergency medicine.

Authors:  Nicolas Javaud; Frédéric Lapostolle; David Sapir; Marie Dubrel; Frédéric Adnet; Olivier Fain
Journal:  Eur J Emerg Med       Date:  2013-08       Impact factor: 2.799

5.  Incidence and characteristics of angioedema associated with enalapril.

Authors:  John B Kostis; Harold J Kim; James Rusnak; Thomas Casale; Allen Kaplan; Jonathan Corren; Elliott Levy
Journal:  Arch Intern Med       Date:  2005-07-25

6.  Ecallantide for the treatment of acute attacks in hereditary angioedema.

Authors:  Marco Cicardi; Robyn J Levy; Donald L McNeil; H Henry Li; Albert L Sheffer; Marilyn Campion; Patrick T Horn; William E Pullman
Journal:  N Engl J Med       Date:  2010-08-05       Impact factor: 91.245

7.  Icatibant: a novel approach to the treatment of angioedema related to the use of angiotensin-converting enzyme inhibitors.

Authors:  Mauro Gallitelli; Michele Alzetta
Journal:  Am J Emerg Med       Date:  2011-11-17       Impact factor: 2.469

8.  Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.

Authors:  Timothy J Craig; Robyn J Levy; Richard L Wasserman; Againdra K Bewtra; David Hurewitz; Krystyna Obtułowicz; Avner Reshef; Bruce Ritchie; Dumitru Moldovan; Todor Shirov; Vesna Grivcheva-Panovska; Peter C Kiessling; Heinz-Otto Keinecke; Jonathan A Bernstein
Journal:  J Allergy Clin Immunol       Date:  2009-09-19       Impact factor: 10.793

9.  Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor.

Authors:  Konrad Bork
Journal:  Allergy Asthma Clin Immunol       Date:  2010-07-28       Impact factor: 3.406

10.  Emerging concepts in the diagnosis and treatment of patients with undifferentiated angioedema.

Authors:  Jonathan A Bernstein; Joseph Moellman
Journal:  Int J Emerg Med       Date:  2012-11-06
View more
  14 in total

1.  Treatment of ACEI-related angioedema with icatibant: a case series.

Authors:  Maria Bova; Mar Guilarte; Anna Sala-Cunill; Paolo Borrelli; Grazia Maria Luisa Rizzelli; Andrea Zanichelli
Journal:  Intern Emerg Med       Date:  2015-02-10       Impact factor: 3.397

Review 2.  Angioedema.

Authors:  Janina Hahn; Thomas K Hoffmann; Bastian Bock; Melanie Nordmann-Kleiner; Susanne Trainotti; Jens Greve
Journal:  Dtsch Arztebl Int       Date:  2017-07-24       Impact factor: 5.594

3.  [Bradykinin-induced angioedema: Definition, pathogenesis, clinical presentation, diagnosis and therapy].

Authors:  J Hahn; M Bas; T K Hoffmann; J Greve
Journal:  HNO       Date:  2015-12       Impact factor: 1.284

Review 4.  Review of Select Practice Parameters, Evidence-Based Treatment Algorithms, and International Guidelines for Hereditary Angioedema.

Authors:  Jaison Jose; Jamie Zacharias; Timothy Craig
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

Review 5.  Management of urticaria: not too complicated, not too simple.

Authors:  M Ferrer; J Bartra; A Giménez-Arnau; I Jauregui; M Labrador-Horrillo; J Ortiz de Frutos; J F Silvestre; J Sastre; M Velasco; A Valero
Journal:  Clin Exp Allergy       Date:  2015-04       Impact factor: 5.018

6.  Drug-Induced Inhibition of Angiotensin Converting Enzyme and Dipeptidyl Peptidase 4 Results in Nearly Therapy Resistant Bradykinin Induced Angioedema: A Case Report.

Authors:  Janina Hahn; Susanne Trainotti; Thomas K Hoffmann; Jens Greve
Journal:  Am J Case Rep       Date:  2017-05-25

Review 7.  Angioedema in the emergency department: a practical guide to differential diagnosis and management.

Authors:  Jonathan A Bernstein; Paolo Cremonesi; Thomas K Hoffmann; John Hollingsworth
Journal:  Int J Emerg Med       Date:  2017-04-13

8.  Value co-creation in healthcare: evidence from innovative therapeutic alternatives for hereditary angioedema.

Authors:  Rosanna Spanò; Nadia Di Paola; Maria Bova; Alessandro Barbarino
Journal:  BMC Health Serv Res       Date:  2018-07-20       Impact factor: 2.655

Review 9.  The Story of Angioedema: from Quincke to Bradykinin.

Authors:  Avner Reshef; Mona Kidon; Iris Leibovich
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 10.817

10.  High attack frequency in patients with angioedema due to C1-inhibitor deficiency is a major determinant in switching to home therapy: a real-life observational study.

Authors:  Veronica Squeglia; Alessandro Barbarino; Maria Bova; Carmela Gravante; Angelica Petraroli; Giuseppe Spadaro; Massimo Triggiani; Arturo Genovese; Gianni Marone
Journal:  Orphanet J Rare Dis       Date:  2016-09-29       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.